aap Implantate AG

XETRA AAQ1.DE

aap Implantate AG Operating Income for the year ending December 31, 2023: USD -5.71 M

aap Implantate AG Operating Income is USD -5.71 M for the year ending December 31, 2023, a -64.58% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

aap Implantate AG Operating Income for the year ending December 31, 2022 was USD -3.47 M, a -13.17% change year over year.
aap Implantate AG Operating Income for the year ending December 31, 2021 was USD -3.06 M, a 67.01% change year over year.
aap Implantate AG Operating Income for the year ending December 31, 2020 was USD -9.29 M, a -14.39% change year over year.
aap Implantate AG Operating Income for the year ending December 31, 2019 was USD -8.12 M, a 12.78% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

XETRA: AAQ1.DE

aap Implantate AG

CEO	Mr. Rubino Di Girolamo
IPO Date	May 11, 1999
Location	Germany
Headquarters	Lorenzweg 5
Employees	87
Sector	Healthcare
Industries Medical Instruments 3D Printing Automotive Parts Composite Materials Glass Hardware & Electronics Pharmaceuticals Plastics

Description

aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Key trends

Past 5 years